Related Experiment Videos
Myocardial SPECT: what do we gain from attenuation correction (and when)?
M Dondi1, G Fagioli, M Salgarello
1Department of Diagnostic Imaging, Nuclear Medicine Unit, C. A. Pizzardi Hospital, Bologna, Italy. maurizio.dondi@ausl.bologna.it
Summary
Attenuation correction in myocardial SPECT significantly improves specificity and normalcy rates for detecting coronary artery disease (CAD). This technique is particularly beneficial for patients with intermediate risk of CAD, leading to more accurate diagnoses.
Area of Science:
- Nuclear Medicine
- Cardiology
- Medical Imaging
Background:
- Coronary artery disease (CAD) assessment relies on myocardial SPECT imaging.
- Accurate interpretation of SPECT images can be challenging due to attenuation artifacts.
- Novel hardware solutions aim to improve image quality and diagnostic accuracy.
Purpose of the Study:
- To evaluate the impact of a new hardware-based attenuation correction (AC) device on myocardial SPECT for CAD assessment.
- To determine which patient risk groups benefit most from this AC technique.
Main Methods:
- Myocardial SPECT was performed on 500 patients using (99m)Tc Tetrofosmin, with and without attenuation correction (AC vs. NAC).
- 130 patients underwent coronary angiography (CAG) for gold-standard comparison.
- SPECT studies were blindly reviewed and classified.
Main Results:
- Specificity for CAD detection increased significantly with AC (91% vs. 73% for NAC, p<0.01).
- Normalcy rate improved with AC (93% vs. 80% for NAC, p<0.05).
- Patients in the intermediate CAD risk group showed the most significant improvement in normal findings (52% to 72%).
Conclusions:
- Attenuation correction in myocardial SPECT enhances specificity and normalcy rates without affecting sensitivity for CAD detection.
- The intermediate risk patient group benefits most from this AC technology.
- AC leads to a higher rate of normal reports, particularly in males.